Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005856-33Phase 3Active
Phase 3, randomised trial in Esophageal stricture comparing Methylprednisolone injection plus dilatation with Control/placebo injection plus dilatation (2 arms). Primary endpoint: Return of dysphagia within six weeks. Started Dec 2006; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005856-33.